Gabon
Hepatitis B
Download HBV dataPrevalence of chronic HBV (HBsAg+)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 5.21 (4.74 - 5.74) | 2019 | Modelled | IHME |
| 5.36 (4.92 - 5.81) | 2018 | Modelled | IHME |
| 5.52 (5.05 - 5.99) | 2017 | Modelled | IHME |
| 5.68 (5.23 - 6.15) | 2016 | Modelled | IHME |
| 5.85 (5.36 - 6.39) | 2015 | Modelled | IHME |
| 6.03 (5.54 - 6.58) | 2014 | Modelled | IHME |
| 6.22 (5.70 - 6.79) | 2013 | Modelled | IHME |
| 6.41 (5.85 - 7) | 2012 | Modelled | IHME |
| 6.6 (5.99 - 7.23) | 2011 | Modelled | IHME |
| 6.77 (6.12 - 7.47) | 2010 | Modelled | IHME |
| 6.94 (6.30 - 7.64) | 2009 | Modelled | IHME |
| 7.11 (6.46 - 7.82) | 2008 | Modelled | IHME |
| 7.27 (6.61 - 7.98) | 2007 | Modelled | IHME |
| 7.43 (6.76 - 8.15) | 2006 | Modelled | IHME |
| 7.57 (6.87 - 8.34) | 2005 | Modelled | IHME |
| 7.71 (7.03 - 8.43) | 2004 | Modelled | IHME |
| 7.84 (7.16 - 8.54) | 2003 | Modelled | IHME |
| 7.96 (7.28 - 8.70) | 2002 | Modelled | IHME |
| 8.09 (7.39 - 8.86) | 2001 | Modelled | IHME |
| 8.21 (7.49 - 8.99) | 2000 | Modelled | IHME |
| 8.34 (7.62 - 9.12) | 1999 | Modelled | IHME |
| 8.47 (7.74 - 9.23) | 1998 | Modelled | IHME |
| 8.6 (7.83 - 9.38) | 1997 | Modelled | IHME |
| 8.73 (7.92 - 9.55) | 1996 | Modelled | IHME |
| 8.88 (8.03 - 9.74) | 1995 | Modelled | IHME |
| 9.04 (8.19 - 9.89) | 1994 | Modelled | IHME |
| 9.22 (8.37 - 10.09) | 1993 | Modelled | IHME |
| 9.4 (8.57 - 10.29) | 1992 | Modelled | IHME |
| 9.59 (8.74 - 10.53) | 1991 | Modelled | IHME |
| 9.8 (8.92 - 10.78) | 1990 | Modelled | IHME |
| 9.13 (7.43 - 11.15) | 2015 | Modelled | WHO |
| 5.1 (3.20 - 6) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
| 11.48 (10.72 - 12.30) | 2013 | Modelled | Schweitzer et al, 2015 |
Showing out of
Show more
Children under-5 years
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 1.21 (0.95 - 1.51) | 2019 | Modelled | IHME |
| 1.29 (1 - 1.60) | 2018 | Modelled | IHME |
| 1.36 (1.05 - 1.71) | 2017 | Modelled | IHME |
| 1.41 (1.10 - 1.74) | 2016 | Modelled | IHME |
| 1.46 (1.14 - 1.85) | 2015 | Modelled | IHME |
| 1.56 (1.22 - 1.96) | 2014 | Modelled | IHME |
| 1.7 (1.34 - 2.13) | 2013 | Modelled | IHME |
| 1.88 (1.48 - 2.35) | 2012 | Modelled | IHME |
| 2.08 (1.64 - 2.61) | 2011 | Modelled | IHME |
| 2.3 (1.82 - 2.93) | 2010 | Modelled | IHME |
| 2.57 (2.03 - 3.22) | 2009 | Modelled | IHME |
| 2.9 (2.31 - 3.62) | 2008 | Modelled | IHME |
| 3.28 (2.62 - 4.09) | 2007 | Modelled | IHME |
| 3.68 (2.92 - 4.59) | 2006 | Modelled | IHME |
| 4.08 (3.23 - 5.13) | 2005 | Modelled | IHME |
| 4.52 (3.59 - 5.63) | 2004 | Modelled | IHME |
| 5.03 (3.99 - 6.21) | 2003 | Modelled | IHME |
| 5.54 (4.38 - 6.80) | 2002 | Modelled | IHME |
| 5.96 (4.71 - 7.36) | 2001 | Modelled | IHME |
| 6.25 (4.92 - 7.80) | 2000 | Modelled | IHME |
| 6.4 (5.07 - 7.90) | 1999 | Modelled | IHME |
| 6.52 (5.15 - 7.97) | 1998 | Modelled | IHME |
| 6.62 (5.21 - 8.08) | 1997 | Modelled | IHME |
| 6.72 (5.26 - 8.31) | 1996 | Modelled | IHME |
| 6.84 (5.33 - 8.52) | 1995 | Modelled | IHME |
| 6.98 (5.46 - 8.63) | 1994 | Modelled | IHME |
| 7.13 (5.64 - 8.84) | 1993 | Modelled | IHME |
| 7.29 (5.78 - 9.06) | 1992 | Modelled | IHME |
| 7.47 (5.92 - 9.21) | 1991 | Modelled | IHME |
| 7.65 (6.08 - 9.55) | 1990 | Modelled | IHME |
| 4.16 (2.99 - 5.67) | 2015 | Modelled | WHO |
Showing out of
Show more
Number of people living with chronic HBV
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 97,158 (88,469 - 106,868) | 1990 | Modelled | IHME |
| 97,536 (88,831 - 107,011) | 1991 | Modelled | IHME |
| 97,942 (89,304 - 107,243) | 1992 | Modelled | IHME |
| 98,381 (89,404 - 107,720) | 1993 | Modelled | IHME |
| 98,856 (89,507 - 108,168) | 1994 | Modelled | IHME |
| 99,381 (89,838 - 108,975) | 1995 | Modelled | IHME |
| 99,972 (90,687 - 109,353) | 1996 | Modelled | IHME |
| 100,619 (91,625 - 109,784) | 1997 | Modelled | IHME |
| 101,285 (92,545 - 110,386) | 1998 | Modelled | IHME |
| 101,909 (93,105 - 111,439) | 1999 | Modelled | IHME |
| 102,436 (93,477 - 112,100) | 2000 | Modelled | IHME |
| 102,896 (94,018 - 112,735) | 2001 | Modelled | IHME |
| 103,337 (94,424 - 112,889) | 2002 | Modelled | IHME |
| 103,710 (94,680 - 113,036) | 2003 | Modelled | IHME |
| 103,961 (94,766 - 113,620) | 2004 | Modelled | IHME |
| 104,054 (94,420 - 114,621) | 2005 | Modelled | IHME |
| 103,964 (94,596 - 114,102) | 2006 | Modelled | IHME |
| 103,698 (94,308 - 113,779) | 2007 | Modelled | IHME |
| 103,260 (93,872 - 113,497) | 2008 | Modelled | IHME |
| 102,669 (93,154 - 113,017) | 2009 | Modelled | IHME |
| 101,952 (92,128 - 112,365) | 2010 | Modelled | IHME |
| 101,033 (91,744 - 110,784) | 2011 | Modelled | IHME |
| 99,885 (91,162 - 109,079) | 2012 | Modelled | IHME |
| 98,596 (90,422 - 107,689) | 2013 | Modelled | IHME |
| 97,256 (89,313 - 106,180) | 2014 | Modelled | IHME |
| 95,955 (87,947 - 104,734) | 2015 | Modelled | IHME |
| 94,710 (87,237 - 102,561) | 2016 | Modelled | IHME |
| 93,505 (85,521 - 101,588) | 2017 | Modelled | IHME |
| 92,351 (84,703 - 100,098) | 2018 | Modelled | IHME |
| 91,259 (82,909 - 100,398) | 2019 | Modelled | IHME |
| 101,000 (63,000 - 118,000) | 2016 | Modelled | Razavi-Shearer et al, 2018 |
Showing out of
Show more
HBV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 6.34 (4.07 - 9.48) | 2019 | Modelled | IHME |
| 6.42 (4.17 - 9.44) | 2018 | Modelled | IHME |
| 6.59 (4.28 - 9.68) | 2017 | Modelled | IHME |
| 6.77 (4.47 - 9.88) | 2016 | Modelled | IHME |
| 7.03 (4.72 - 10.20) | 2015 | Modelled | IHME |
| 7.3 (4.95 - 10.60) | 2014 | Modelled | IHME |
| 7.64 (5.28 - 11) | 2013 | Modelled | IHME |
| 8.02 (5.54 - 11.60) | 2012 | Modelled | IHME |
| 8.33 (5.78 - 11.90) | 2011 | Modelled | IHME |
| 8.49 (5.84 - 12.10) | 2010 | Modelled | IHME |
| 8.74 (6.11 - 12.40) | 2009 | Modelled | IHME |
| 8.89 (6.30 - 12.70) | 2008 | Modelled | IHME |
| 8.88 (6.32 - 12.40) | 2007 | Modelled | IHME |
| 8.88 (6.33 - 12.30) | 2006 | Modelled | IHME |
| 8.91 (6.34 - 12.40) | 2005 | Modelled | IHME |
| 9.1 (6.49 - 12.60) | 2004 | Modelled | IHME |
| 9.29 (6.67 - 12.90) | 2003 | Modelled | IHME |
| 9.36 (6.73 - 12.80) | 2002 | Modelled | IHME |
| 9.61 (6.82 - 13.30) | 2001 | Modelled | IHME |
| 9.62 (6.75 - 13.40) | 2000 | Modelled | IHME |
| 9.63 (6.85 - 13.20) | 1999 | Modelled | IHME |
| 9.89 (6.94 - 13.60) | 1998 | Modelled | IHME |
| 10 (6.99 - 13.80) | 1997 | Modelled | IHME |
| 10.2 (7.07 - 14.10) | 1996 | Modelled | IHME |
| 10.3 (7.07 - 14.20) | 1995 | Modelled | IHME |
| 10.1 (6.98 - 13.90) | 1994 | Modelled | IHME |
| 10.2 (6.97 - 13.90) | 1993 | Modelled | IHME |
| 10.4 (7.13 - 14.40) | 1992 | Modelled | IHME |
| 10.5 (7.18 - 14.60) | 1991 | Modelled | IHME |
| 10.6 (7.20 - 14.80) | 1990 | Modelled | IHME |
Showing out of
Show more
HBV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 111 (71 - 166) | 2019 | Modelled | IHME |
| 111 (72 - 163) | 2018 | Modelled | IHME |
| 112 (72 - 164) | 2017 | Modelled | IHME |
| 113 (75 - 165) | 2016 | Modelled | IHME |
| 115 (77 - 168) | 2015 | Modelled | IHME |
| 118 (80 - 170) | 2014 | Modelled | IHME |
| 121 (84 - 175) | 2013 | Modelled | IHME |
| 125 (86 - 180) | 2012 | Modelled | IHME |
| 128 (88 - 183) | 2011 | Modelled | IHME |
| 128 (88 - 183) | 2010 | Modelled | IHME |
| 129 (90 - 184) | 2009 | Modelled | IHME |
| 129 (92 - 184) | 2008 | Modelled | IHME |
| 127 (90 - 177) | 2007 | Modelled | IHME |
| 124 (89 - 173) | 2006 | Modelled | IHME |
| 122 (87 - 170) | 2005 | Modelled | IHME |
| 123 (88 - 170) | 2004 | Modelled | IHME |
| 123 (88 - 171) | 2003 | Modelled | IHME |
| 122 (87 - 166) | 2002 | Modelled | IHME |
| 122 (87 - 169) | 2001 | Modelled | IHME |
| 120 (84 - 167) | 2000 | Modelled | IHME |
| 118 (84 - 162) | 1999 | Modelled | IHME |
| 118 (83 - 163) | 1998 | Modelled | IHME |
| 118 (82 - 161) | 1997 | Modelled | IHME |
| 117 (81 - 161) | 1996 | Modelled | IHME |
| 115 (79 - 159) | 1995 | Modelled | IHME |
| 111 (76 - 152) | 1994 | Modelled | IHME |
| 108 (74 - 148) | 1993 | Modelled | IHME |
| 109 (74 - 150) | 1992 | Modelled | IHME |
| 107 (73 - 148) | 1991 | Modelled | IHME |
| 105 (71 - 147) | 1990 | Modelled | IHME |
| 186 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HBV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 22 (17 - 30) | 2019 | Modelled | IHME |
| 22 (17 - 30) | 2018 | Modelled | IHME |
| 23 (17 - 31) | 2017 | Modelled | IHME |
| 23 (17 - 30) | 2016 | Modelled | IHME |
| 23 (17 - 31) | 2015 | Modelled | IHME |
| 23 (18 - 31) | 2014 | Modelled | IHME |
| 24 (18 - 31) | 2013 | Modelled | IHME |
| 24 (18 - 31) | 2012 | Modelled | IHME |
| 24 (18 - 32) | 2011 | Modelled | IHME |
| 24 (18 - 32) | 2010 | Modelled | IHME |
| 24 (18 - 31) | 2009 | Modelled | IHME |
| 24 (18 - 31) | 2008 | Modelled | IHME |
| 23 (18 - 30) | 2007 | Modelled | IHME |
| 23 (17 - 30) | 2006 | Modelled | IHME |
| 23 (17 - 30) | 2005 | Modelled | IHME |
| 23 (17 - 30) | 2004 | Modelled | IHME |
| 23 (17 - 30) | 2003 | Modelled | IHME |
| 23 (17 - 30) | 2002 | Modelled | IHME |
| 23 (17 - 30) | 2001 | Modelled | IHME |
| 23 (17 - 30) | 2000 | Modelled | IHME |
| 23 (17 - 29) | 1999 | Modelled | IHME |
| 23 (17 - 30) | 1998 | Modelled | IHME |
| 23 (17 - 30) | 1997 | Modelled | IHME |
| 22 (17 - 29) | 1996 | Modelled | IHME |
| 22 (16 - 29) | 1995 | Modelled | IHME |
| 22 (16 - 29) | 1994 | Modelled | IHME |
| 22 (16 - 29) | 1993 | Modelled | IHME |
| 22 (16 - 29) | 1992 | Modelled | IHME |
| 22 (16 - 29) | 1991 | Modelled | IHME |
| 22 (16 - 28) | 1990 | Modelled | IHME |
Showing out of
Show more
Coverage of 3-dose hepatitis B vaccine
Infants
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 70 | 2019 | Survey/reported | WHO/UNICEF |
| 63 | 2020 | Survey/reported | WHO/UNICEF |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Hepatitis C
Download HCV dataPrevalence of chronic HCV (RNA+/cAg)
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 3.64 (2.98 - 4.51) | 2019 | Modelled | IHME |
| 3.65 (3 - 4.51) | 2018 | Modelled | IHME |
| 3.66 (2.99 - 4.51) | 2017 | Modelled | IHME |
| 3.66 (2.99 - 4.54) | 2016 | Modelled | IHME |
| 3.67 (2.96 - 4.55) | 2015 | Modelled | IHME |
| 3.68 (3 - 4.55) | 2014 | Modelled | IHME |
| 3.71 (3.04 - 4.53) | 2013 | Modelled | IHME |
| 3.75 (3.10 - 4.54) | 2012 | Modelled | IHME |
| 3.79 (3.17 - 4.57) | 2011 | Modelled | IHME |
| 3.84 (3.20 - 4.58) | 2010 | Modelled | IHME |
| 3.9 (3.28 - 4.62) | 2009 | Modelled | IHME |
| 3.98 (3.36 - 4.68) | 2008 | Modelled | IHME |
| 4.07 (3.41 - 4.79) | 2007 | Modelled | IHME |
| 4.16 (3.48 - 4.94) | 2006 | Modelled | IHME |
| 4.23 (3.54 - 5.03) | 2005 | Modelled | IHME |
| 4.28 (3.61 - 5.08) | 2004 | Modelled | IHME |
| 4.34 (3.67 - 5.13) | 2003 | Modelled | IHME |
| 4.38 (3.72 - 5.19) | 2002 | Modelled | IHME |
| 4.42 (3.74 - 5.22) | 2001 | Modelled | IHME |
| 4.46 (3.76 - 5.28) | 2000 | Modelled | IHME |
| 4.48 (3.76 - 5.33) | 1999 | Modelled | IHME |
| 4.5 (3.74 - 5.38) | 1998 | Modelled | IHME |
| 4.52 (3.71 - 5.49) | 1997 | Modelled | IHME |
| 4.54 (3.72 - 5.57) | 1996 | Modelled | IHME |
| 4.57 (3.69 - 5.69) | 1995 | Modelled | IHME |
| 4.61 (3.70 - 5.78) | 1994 | Modelled | IHME |
| 4.68 (3.76 - 5.87) | 1993 | Modelled | IHME |
| 4.75 (3.81 - 5.95) | 1992 | Modelled | IHME |
| 4.84 (3.89 - 6.06) | 1991 | Modelled | IHME |
| 4.94 (4 - 6.15) | 1990 | Modelled | IHME |
| 7 (5.10 - 7.30) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 4.26 (3.09 - 4.41) | 2019 | Modelled | Dugan et al., 2021 |
Prevalence of anti-HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 11.2 (2.10 - 20.70) | 2014 | Survey/reported | Gower et al, 2014 |
Number of people living with chronic HCV (RNA+/cAg)
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 48,996 (39,663 - 61,025) | 1990 | Modelled | IHME |
| 49,245 (39,569 - 61,598) | 1991 | Modelled | IHME |
| 49,542 (39,747 - 62,047) | 1992 | Modelled | IHME |
| 49,928 (40,162 - 62,623) | 1993 | Modelled | IHME |
| 50,445 (40,492 - 63,217) | 1994 | Modelled | IHME |
| 51,148 (41,340 - 63,680) | 1995 | Modelled | IHME |
| 51,998 (42,542 - 63,789) | 1996 | Modelled | IHME |
| 52,904 (43,416 - 64,278) | 1997 | Modelled | IHME |
| 53,835 (44,766 - 64,408) | 1998 | Modelled | IHME |
| 54,744 (45,943 - 65,079) | 1999 | Modelled | IHME |
| 55,585 (46,915 - 65,833) | 2000 | Modelled | IHME |
| 56,305 (47,601 - 66,449) | 2001 | Modelled | IHME |
| 56,896 (48,223 - 67,340) | 2002 | Modelled | IHME |
| 57,375 (48,593 - 67,858) | 2003 | Modelled | IHME |
| 57,758 (48,633 - 68,516) | 2004 | Modelled | IHME |
| 58,078 (48,661 - 69,060) | 2005 | Modelled | IHME |
| 58,200 (48,739 - 69,085) | 2006 | Modelled | IHME |
| 58,067 (48,683 - 68,298) | 2007 | Modelled | IHME |
| 57,836 (48,824 - 67,944) | 2008 | Modelled | IHME |
| 57,684 (48,469 - 68,326) | 2009 | Modelled | IHME |
| 57,804 (48,208 - 68,938) | 2010 | Modelled | IHME |
| 58,107 (48,590 - 69,963) | 2011 | Modelled | IHME |
| 58,419 (48,350 - 70,741) | 2012 | Modelled | IHME |
| 58,810 (48,219 - 71,823) | 2013 | Modelled | IHME |
| 59,350 (48,336 - 73,420) | 2014 | Modelled | IHME |
| 60,110 (48,558 - 74,703) | 2015 | Modelled | IHME |
| 61,035 (49,806 - 75,711) | 2016 | Modelled | IHME |
| 61,978 (50,710 - 76,476) | 2017 | Modelled | IHME |
| 62,870 (51,590 - 77,597) | 2018 | Modelled | IHME |
| 63,716 (52,158 - 78,876) | 2019 | Modelled | IHME |
| 124,000 (90,000 - 129,000) | 2015 | Modelled | Blach et al, 2017 |
Showing out of
Show more
Women of childbearing age (15–49 years)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 23,100 (16,700 - 23,900) | 2019 | Modelled | Dugan et al., 2021 |
HCV-related death rate
National
Download| Value (per 100,000) | Year | Type | Source |
|---|---|---|---|
| 8.33 (5.39 - 11.70) | 2019 | Modelled | IHME |
| 8.37 (5.48 - 11.80) | 2018 | Modelled | IHME |
| 8.35 (5.50 - 11.60) | 2017 | Modelled | IHME |
| 8.15 (5.38 - 11.40) | 2016 | Modelled | IHME |
| 8 (5.35 - 11.10) | 2015 | Modelled | IHME |
| 7.9 (5.33 - 11) | 2014 | Modelled | IHME |
| 7.85 (5.31 - 11) | 2013 | Modelled | IHME |
| 7.86 (5.32 - 11) | 2012 | Modelled | IHME |
| 7.88 (5.46 - 11) | 2011 | Modelled | IHME |
| 7.9 (5.48 - 11) | 2010 | Modelled | IHME |
| 8.11 (5.58 - 11.40) | 2009 | Modelled | IHME |
| 8.29 (5.79 - 11.70) | 2008 | Modelled | IHME |
| 8.34 (5.88 - 11.60) | 2007 | Modelled | IHME |
| 8.41 (5.97 - 11.70) | 2006 | Modelled | IHME |
| 8.46 (6.01 - 11.70) | 2005 | Modelled | IHME |
| 8.64 (6.12 - 11.90) | 2004 | Modelled | IHME |
| 8.78 (6.20 - 11.90) | 2003 | Modelled | IHME |
| 8.81 (6.35 - 11.90) | 2002 | Modelled | IHME |
| 9.01 (6.41 - 12.20) | 2001 | Modelled | IHME |
| 9.01 (6.50 - 12.10) | 2000 | Modelled | IHME |
| 9.02 (6.51 - 12.10) | 1999 | Modelled | IHME |
| 9.24 (6.72 - 12.50) | 1998 | Modelled | IHME |
| 9.39 (6.81 - 12.60) | 1997 | Modelled | IHME |
| 9.56 (6.86 - 12.80) | 1996 | Modelled | IHME |
| 9.63 (6.84 - 13.10) | 1995 | Modelled | IHME |
| 9.51 (6.76 - 12.90) | 1994 | Modelled | IHME |
| 9.54 (6.85 - 13) | 1993 | Modelled | IHME |
| 9.77 (7.03 - 13.40) | 1992 | Modelled | IHME |
| 9.9 (7.04 - 13.60) | 1991 | Modelled | IHME |
| 9.99 (7.08 - 13.70) | 1990 | Modelled | IHME |
Showing out of
Show more
HCV-related deaths
National
Download| Value | Year | Type | Source |
|---|---|---|---|
| 146 (94 - 205) | 2019 | Modelled | IHME |
| 144 (94 - 203) | 2018 | Modelled | IHME |
| 142 (93 - 196) | 2017 | Modelled | IHME |
| 136 (90 - 190) | 2016 | Modelled | IHME |
| 131 (88 - 183) | 2015 | Modelled | IHME |
| 127 (86 - 178) | 2014 | Modelled | IHME |
| 124 (84 - 174) | 2013 | Modelled | IHME |
| 123 (83 - 171) | 2012 | Modelled | IHME |
| 121 (84 - 169) | 2011 | Modelled | IHME |
| 119 (83 - 166) | 2010 | Modelled | IHME |
| 120 (82 - 169) | 2009 | Modelled | IHME |
| 120 (84 - 169) | 2008 | Modelled | IHME |
| 119 (84 - 166) | 2007 | Modelled | IHME |
| 118 (84 - 164) | 2006 | Modelled | IHME |
| 116 (83 - 161) | 2005 | Modelled | IHME |
| 116 (83 - 161) | 2004 | Modelled | IHME |
| 116 (82 - 158) | 2003 | Modelled | IHME |
| 114 (82 - 154) | 2002 | Modelled | IHME |
| 115 (82 - 155) | 2001 | Modelled | IHME |
| 112 (81 - 151) | 2000 | Modelled | IHME |
| 110 (80 - 148) | 1999 | Modelled | IHME |
| 111 (80 - 149) | 1998 | Modelled | IHME |
| 110 (80 - 148) | 1997 | Modelled | IHME |
| 109 (78 - 147) | 1996 | Modelled | IHME |
| 108 (77 - 147) | 1995 | Modelled | IHME |
| 104 (74 - 141) | 1994 | Modelled | IHME |
| 102 (73 - 139) | 1993 | Modelled | IHME |
| 102 (73 - 140) | 1992 | Modelled | IHME |
| 101 (72 - 138) | 1991 | Modelled | IHME |
| 99 (70 - 136) | 1990 | Modelled | IHME |
| 182 | 2016 | Modelled | WHO |
Showing out of
Show more
Percent of liver cancer deaths attributable to HCV
National
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 45 (36 - 54) | 2019 | Modelled | IHME |
| 45 (36 - 54) | 2018 | Modelled | IHME |
| 45 (36 - 54) | 2017 | Modelled | IHME |
| 45 (36 - 54) | 2016 | Modelled | IHME |
| 45 (36 - 53) | 2015 | Modelled | IHME |
| 45 (36 - 53) | 2014 | Modelled | IHME |
| 45 (36 - 53) | 2013 | Modelled | IHME |
| 45 (36 - 53) | 2012 | Modelled | IHME |
| 45 (36 - 53) | 2011 | Modelled | IHME |
| 45 (36 - 53) | 2010 | Modelled | IHME |
| 44 (36 - 53) | 2009 | Modelled | IHME |
| 45 (36 - 53) | 2008 | Modelled | IHME |
| 45 (36 - 53) | 2007 | Modelled | IHME |
| 45 (36 - 53) | 2006 | Modelled | IHME |
| 45 (36 - 53) | 2005 | Modelled | IHME |
| 45 (37 - 54) | 2004 | Modelled | IHME |
| 45 (36 - 54) | 2003 | Modelled | IHME |
| 46 (36 - 54) | 2002 | Modelled | IHME |
| 46 (37 - 54) | 2001 | Modelled | IHME |
| 46 (37 - 54) | 2000 | Modelled | IHME |
| 46 (37 - 54) | 1999 | Modelled | IHME |
| 46 (37 - 54) | 1998 | Modelled | IHME |
| 46 (37 - 54) | 1997 | Modelled | IHME |
| 46 (37 - 54) | 1996 | Modelled | IHME |
| 46 (37 - 54) | 1995 | Modelled | IHME |
| 46 (37 - 54) | 1994 | Modelled | IHME |
| 46 (37 - 54) | 1993 | Modelled | IHME |
| 46 (37 - 54) | 1992 | Modelled | IHME |
| 46 (37 - 54) | 1991 | Modelled | IHME |
| 46 (37 - 54) | 1990 | Modelled | IHME |
Showing out of
Show more
Number of needles/syringes per PWID per year
People who inject drugs (PWID)
Download| Value | Year | Type | Source |
|---|---|---|---|
| 0 (0 - 0) | 2016 | Survey/reported | Harm Reduction International, 2016 |
Percent of PWID accessing OST
People who inject drugs (PWID)
Download| Value (%) | Year | Type | Source |
|---|---|---|---|
| 0 | 2016 | Survey/reported | Harm Reduction International, 2016 |
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
Overview
HBV elimination goal
HCV elimination goal
Prevalence (national)
Modelled
Survey/surveillance
No data available
Hepatitis related deaths (national)
Prevalence < 5
HBV
1.21
(%)
2019, latest modelled
(0.95 - 1.51(%))
IHME
Prevalence PWID
No data available
Birth dose vaccination coverage (national)
Survey/surveillance
No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines